Closed
SectorHealthcare
290.51 -0.19
24h
Min
284.59
Max
294.13
Income | -14M -73M |
---|---|
Sales | 34M 137M |
EPS | -3.32 |
Profit margin | -53.361 |
Employees | 528 |
EBITDA | -14M -70M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +45.67% upside |
Next Earnings | 6 sie 2025 |
---|
Market Cap | -637M 6.7B |
---|---|
Previous open | 290.7 |
Previous close | 290.51 |
By Acuity
50%
50%
173 / 382 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 425.08 USD 45.67%
High 539 USD
Low 248 USD
Based on 14 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$